VCIM
Velan Capital Investment Management Portfolio holdings
AUM
$99.9M
This Quarter Return
+87.69%
1 Year Return
+37.46%
3 Year Return
+659.14%
5 Year Return
–
10 Year Return
–
AUM
$185M
AUM Growth
+$185M
(+31%)
Cap. Flow
-$291M
Cap. Flow
% of AUM
-157.22%
Top 10 Holdings %
Top 10 Hldgs %
92.87%
Holding
27
New
6
Increased
2
Reduced
4
Closed
6
Top Buys
| 1 |
Outlook Therapeutics
OTLK
|
$5.97M |
| 2 |
TELA Bio
TELA
|
$3.79M |
| 3 |
Aquestive Therapeutics
AQST
|
$2.56M |
| 4 |
Milestone Pharmaceuticals
MIST
|
$1.16M |
| 5 |
Rezolute
RZLT
|
$1.02M |
Top Sells
| 1 |
Jasper Therapeutics
JSPR
|
$279M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
$5.62M |
| 3 |
Roivant Sciences
ROIV
|
$5.62M |
| 4 |
Lantheus
LNTH
|
$4.65M |
| 5 |
ADMA Biologics
ADMA
|
$4.01M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – |
0
| – | – |
|
|
IMGN
27
DELISTED
Immunogen Inc
IMGN
| – | – |
-189,500
| Closed | -$5.62M |
|